Neulasta Onpro: a coup de grâce?

Humans Filgrastim / therapeutic use Polyethylene Glycols / therapeutic use Biosimilar Pharmaceuticals

Journal

The American journal of managed care
ISSN: 1936-2692
Titre abrégé: Am J Manag Care
Pays: United States
ID NLM: 9613960

Informations de publication

Date de publication:
01 03 2023
Historique:
entrez: 22 3 2023
pubmed: 23 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

With the rapid decline in average sales price of reference pegfilgrastim products due to biosimilar competition, health care institutions and payers may grapple with coverage of Neulasta Onpro.

Identifiants

DOI: 10.37765/ajmc.2023.89331 PMID: 36947018
pubmed: 36947018
doi: 10.37765/ajmc.2023.89331
pii: 89331
doi:

Substances chimiques

pegfilgrastim 3A58010674
Filgrastim PVI5M0M1GW
Polyethylene Glycols 3WJQ0SDW1A
Biosimilar Pharmaceuticals 0

Types de publication

Journal Article

Langues

eng

Pagination

e69-e70

Auteurs

Chelsee J Jensen (CJ)

Division of Supply Chain Management, Mayo Clinic, 200 1st St SW, Rochester, MN 55905. Email: Jensen.chelsee@mayo.edu.

Caleb J Scheckel (CJ)

Ronald S Go (RS)

Aakash Desai (A)

Scott A Soefje (SA)

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Neulasta Onpro: a coup de grâce?
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Facteurs de croissance hématopoïétique › Facteurs de stimulation des colonies › Facteur de stimulation des colonies de granulocytes › Filgrastim › Neulasta Onpro: a coup de grâce?
questionsmedicales.fr › Technologie, industrie et agriculture › Produits manufacturés › Matériaux biomédicaux et dentaires › Polymères › Polyéthylène glycols › Neulasta Onpro: a coup de grâce?
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Produits pharmaceutiques biosimilaires › Neulasta Onpro: a coup de grâce?